{
  "id": 19696957,
  "title": "New guidance outlines use of first immunotherapy for children newly diagnosed with type 1 diabetes",
  "url": "https://urgent.news/2026/11/12/new-guidance-outlines-use-of-first-immunotherapy-for-children-newly",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-12T19:20:29.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-guidance-outlines-immunotherapy-children-newly.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "For the first time, children ages 8 to 17 who are newly diagnosed with type 1 diabetes have access to an approved treatment that targets the underlying autoimmune disease, rather than solely managing blood sugar levels with insulin.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}